EUVIMEDEUVIMED entdecken
Crossref

Programmed cell death protein 1 (PD-1) regulates metabolic activity of regulatory T cells in ischemia-induced acute kidney injury

Oliver B Pelletier, Murat Dogan, Christopher O'Neill iD, Vikram Sabapathy, Didier Portilla, Rahul Sharma iD

The Journal of Immunology · 01.10.2026 · 215 (10)

DOI: 10.1093/jimmun/vkag234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 07.10.2026. Verfasst von Oliver B Pelletier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville,…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Acute Kidney Injury, Programmed Cell Death 1 Receptor, Reperfusion Injury. Die Arbeit nennt 69 Literaturangaben. Gefördert von: NIDDK NIH HHS, Virginia Catalyst, Juvenile Diabetes Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitor (ICPI) therapy, targeting Programmed cell death protein 1 (PD-1) and its ligands PD-L1 and PD-L2, have revolutionized cancer care. However, ICPI is linked to immune-related adverse events, including nephropathy manifesting as acute kidney injury (AKI), a rapid decline in kidney function, often progressing to renal failure. Regulatory T cells (Tregs) could mitigate AKI, caused by ischemia-reperfusion injury (IRI). Treg stability and function rely on cellular metabolism, with a distinct preference for oxidative phosphorylation (OXPHOS) over glycolysis. Although PD-1 is known to regulate metabolism of CD8 T cells, its role in controlling OXPHOS in Tregs remains underexplored. We demonstrate that PD-1 knockout (KO) mice have worse renal function after IRI when compared to wild-type mice. PD-1–deficient Tregs lose their protective ability against AKI despite retaining in vitro suppressive activity and Foxp3 expression. Transcriptomic analysis reveals altered expression of genes linked to function, proliferation, and mitochondrial metabolism in PD-1 KO Tregs as compared to wild-type Tregs. PD-1 KO Tregs exhibit reduced mitochondrial mass, membrane potential, biogenesis, and dynamics, leading to impaired mitochondrial fitness and trends for reduced expression of fatty acid transporters CD36 and Cpt1a and Glut1. Loss of PD-1 expression or antibody-mediated blockade of PD-1 attenuated OXPHOS and expression of genes related to mitochondrial metabolism in Tregs. These metabolic defects may stem from morphological alterations in mitochondria, highlighting the critical role of PD-1 in Treg-mediated nephroprotection. Our findings reveal the metabolic vulnerability of PD-1–deficient Tregs and underscore the importance of PD-1 in Treg-mediated protection against AKI with implications for ICPI-related nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAcute Kidney InjuryProgrammed Cell Death 1 ReceptorReperfusion InjuryAnimalsMiceMice, KnockoutOxidative PhosphorylationMitochondriaMice, Inbred C57BLMaleKidney

Stichwörter der Autor:innen

AKIPD-1Tregmetabolismmitochondria

Substanzen

Programmed Cell Death 1 ReceptorPdcd1 protein, mouse

Autor:innen und Institutionen

  • Center for Immunity, Inflammation and Regenerative Medicine, Division of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.

ORCID-Profile: Christopher O'Neill, Rahul Sharma

Förderung

  • NIDDK NIH HHS
  • Virginia Catalyst
  • Juvenile Diabetes Research Foundation
  • IGNITE KUH Fellowships
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Pelletier, O. B., Dogan, M., O'Neill, C., Sabapathy, V., Portilla, D., & Sharma, R. (2026). Programmed cell death protein 1 (PD-1) regulates metabolic activity of regulatory T cells in ischemia-induced acute kidney injury. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag234

Vancouver

Pelletier OB, Dogan M, O'Neill C, Sabapathy V, Portilla D, Sharma R. Programmed cell death protein 1 (PD-1) regulates metabolic activity of regulatory T cells in ischemia-induced acute kidney injury. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag234

BibTeX
@article{Pelletier2026,
  author = {Pelletier, Oliver B and Dogan, Murat and O'Neill, Christopher and Sabapathy, Vikram and Portilla, Didier and Sharma, Rahul},
  title = {Programmed cell death protein 1 (PD-1) regulates metabolic activity of regulatory T cells in ischemia-induced acute kidney injury},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {10},
  doi = {10.1093/jimmun/vkag234}
}
Kostenlos starten →